中华肝脏病杂志
中華肝髒病雜誌
중화간장병잡지
CHINESE JOURNAL OF HEPATOLOGY
2014年
6期
445-450
,共6页
刘静%柳银兰%杨文君%罗燕%庄振杰%焦其彬%陈建玉%卞冬雪%马晓洁
劉靜%柳銀蘭%楊文君%囉燕%莊振傑%焦其彬%陳建玉%卞鼕雪%馬曉潔
류정%류은란%양문군%라연%장진걸%초기빈%진건옥%변동설%마효길
模型,动物%脂肪肝%肝炎,脂肪性,非酒精性%高脂高果糖饮食
模型,動物%脂肪肝%肝炎,脂肪性,非酒精性%高脂高果糖飲食
모형,동물%지방간%간염,지방성,비주정성%고지고과당음식
Models,animal%Fatty liver%Steatohepatitis,non-alcoholic%High fat and high fructose diet
目的 采用高脂高果糖饮食建立符合人类饮食习惯的非酒精性脂肪性肝炎(NASH)小鼠模型.方法 6周龄C3H野生型小鼠120只按体质量随机分到高脂高果糖组、高脂组、高果糖组、对照组各30只予以相应喂养,4、8、16周末分批处死小鼠,检测体质量、肝湿重、肝功能、脂代谢等NASH相关指标,肝组织HE、油红O染色评价病理学改变.计量资料两组间均数比较用t检验和Wilcoxon秩和检验,多组间均数比较采用方差分析,计数资料采用x2检验和Fisher确切概率法.结果 与同时点对照组比较,高脂高果糖组和高脂组小鼠体质量、肝湿重增加,油红O染色面积、密度增加,HE染色显示随造模时间延长出现不同程度脂肪变伴炎症灶,高脂高果糖组更明显,造模结束时80%非酒精性脂肪性肝病评分≥5,伴窦周纤维化.血清检测示:4周末,高脂高果糖组和高脂组总胆固醇及高、低密度脂蛋白明显增高;8周末,高脂高果糖组和高脂组血清高、低密度脂蛋白增加明显;16周末,高脂高果糖组、高脂组、高果糖组、对照组ALT分别为(108.5±93.34)U/L、(44.30±35.71)U/L、(46.70±17.95)U/L、(24.70±6.57)U/L,F=5.099,P=0.005;AST分别为(316.30±208.98) U/L、(132.12±75.43) U/L、(143.30±38.53) U/L、(122.60±12.76) U/L,F=6.654,P=0.001;总胆固醇分别为(5.18±0.58) mmol/L、(3.94±0.75)mmol/L、(2.30±0.50) mmol/L、(2.02±0.24) mmol/L,F=72.470,P=0.000;高密度脂蛋白分别为(3.05±0.49) mmol/L、(2.65±0.54) mmol/L、(1.77±0.47) mmol/L、(1.58±0.16)mmol/L,F=25.413,P=0.000;低密度脂蛋白分别为(1.11±0.23) mmol/L、(0.72±0.17)mmol/L、(0.27±0.04) mmol/L、(0.20±0.05) mmol/L,F=83.297,P=0.000.高果糖组组织病理学、血清学改变均不明显.结论 高脂高果糖饮食喂饲4、8、16周可诱导小鼠出现可模拟NASH的疾病进程,出现典型的NASH肝组织学和肥胖等代谢表型.
目的 採用高脂高果糖飲食建立符閤人類飲食習慣的非酒精性脂肪性肝炎(NASH)小鼠模型.方法 6週齡C3H野生型小鼠120隻按體質量隨機分到高脂高果糖組、高脂組、高果糖組、對照組各30隻予以相應餵養,4、8、16週末分批處死小鼠,檢測體質量、肝濕重、肝功能、脂代謝等NASH相關指標,肝組織HE、油紅O染色評價病理學改變.計量資料兩組間均數比較用t檢驗和Wilcoxon秩和檢驗,多組間均數比較採用方差分析,計數資料採用x2檢驗和Fisher確切概率法.結果 與同時點對照組比較,高脂高果糖組和高脂組小鼠體質量、肝濕重增加,油紅O染色麵積、密度增加,HE染色顯示隨造模時間延長齣現不同程度脂肪變伴炎癥竈,高脂高果糖組更明顯,造模結束時80%非酒精性脂肪性肝病評分≥5,伴竇週纖維化.血清檢測示:4週末,高脂高果糖組和高脂組總膽固醇及高、低密度脂蛋白明顯增高;8週末,高脂高果糖組和高脂組血清高、低密度脂蛋白增加明顯;16週末,高脂高果糖組、高脂組、高果糖組、對照組ALT分彆為(108.5±93.34)U/L、(44.30±35.71)U/L、(46.70±17.95)U/L、(24.70±6.57)U/L,F=5.099,P=0.005;AST分彆為(316.30±208.98) U/L、(132.12±75.43) U/L、(143.30±38.53) U/L、(122.60±12.76) U/L,F=6.654,P=0.001;總膽固醇分彆為(5.18±0.58) mmol/L、(3.94±0.75)mmol/L、(2.30±0.50) mmol/L、(2.02±0.24) mmol/L,F=72.470,P=0.000;高密度脂蛋白分彆為(3.05±0.49) mmol/L、(2.65±0.54) mmol/L、(1.77±0.47) mmol/L、(1.58±0.16)mmol/L,F=25.413,P=0.000;低密度脂蛋白分彆為(1.11±0.23) mmol/L、(0.72±0.17)mmol/L、(0.27±0.04) mmol/L、(0.20±0.05) mmol/L,F=83.297,P=0.000.高果糖組組織病理學、血清學改變均不明顯.結論 高脂高果糖飲食餵飼4、8、16週可誘導小鼠齣現可模擬NASH的疾病進程,齣現典型的NASH肝組織學和肥胖等代謝錶型.
목적 채용고지고과당음식건립부합인류음식습관적비주정성지방성간염(NASH)소서모형.방법 6주령C3H야생형소서120지안체질량수궤분도고지고과당조、고지조、고과당조、대조조각30지여이상응위양,4、8、16주말분비처사소서,검측체질량、간습중、간공능、지대사등NASH상관지표,간조직HE、유홍O염색평개병이학개변.계량자료량조간균수비교용t검험화Wilcoxon질화검험,다조간균수비교채용방차분석,계수자료채용x2검험화Fisher학절개솔법.결과 여동시점대조조비교,고지고과당조화고지조소서체질량、간습중증가,유홍O염색면적、밀도증가,HE염색현시수조모시간연장출현불동정도지방변반염증조,고지고과당조경명현,조모결속시80%비주정성지방성간병평분≥5,반두주섬유화.혈청검측시:4주말,고지고과당조화고지조총담고순급고、저밀도지단백명현증고;8주말,고지고과당조화고지조혈청고、저밀도지단백증가명현;16주말,고지고과당조、고지조、고과당조、대조조ALT분별위(108.5±93.34)U/L、(44.30±35.71)U/L、(46.70±17.95)U/L、(24.70±6.57)U/L,F=5.099,P=0.005;AST분별위(316.30±208.98) U/L、(132.12±75.43) U/L、(143.30±38.53) U/L、(122.60±12.76) U/L,F=6.654,P=0.001;총담고순분별위(5.18±0.58) mmol/L、(3.94±0.75)mmol/L、(2.30±0.50) mmol/L、(2.02±0.24) mmol/L,F=72.470,P=0.000;고밀도지단백분별위(3.05±0.49) mmol/L、(2.65±0.54) mmol/L、(1.77±0.47) mmol/L、(1.58±0.16)mmol/L,F=25.413,P=0.000;저밀도지단백분별위(1.11±0.23) mmol/L、(0.72±0.17)mmol/L、(0.27±0.04) mmol/L、(0.20±0.05) mmol/L,F=83.297,P=0.000.고과당조조직병이학、혈청학개변균불명현.결론 고지고과당음식위사4、8、16주가유도소서출현가모의NASH적질병진정,출현전형적NASH간조직학화비반등대사표형.
Objective To develop and evaluate a mouse model of nonalcoholic steatohepatitis (NASH) induced by a high-fat and high-fructose (HFHFr) diet.Methods Six-week-old C3H mice were randomly divided into groups for HFHFr diet experimental modeling,high fat-only (HF) diet controls,high fructose-only (HFr) diet controls,and standard chow (SC) diet controls.The standard HFHFr diet was modified so that it consisted of 76.5% standard chow,12% lard,1% cholesterol,5% egg yolk powder,5% whole milk powder,and 0.5% sodium cholate,along with 20% fructose drinking water.At the end of experimental weeks 4,8,and 16,measurements were taken for the NASH-related parameters of body mass,serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST),lipid profile,and wet liver weight (upon sacrifice).In addition,histological changes in the liver were evaluated by hematoxylin-eosin (HE) and oil red O staining.The significance of differences between groups was assessed by statistical analysis,using the methods of t-test,Wilcoxon rank sum test,x2 test,F test or Fisher's test as appropriate.Results As compared to the mice in the SC group at the corresponding time points,the mice in the HFHFr and HF groups showed significantly higher body mass and wet liver weight,as well as more extensive and robust lipid disposition in hepatic tissues as evidenced by oil red O staining.However,HE staining indicated that the HFHFr and HF groups had different degrees of macrosteatosis accompanied with intralobular inflammatory foci,with the former showing more remarkable NASH-related histological changes.Analysis at the end of week 16 showed that about 80% of the mice in the HFHFr group had developed NASH [nonalcoholic fatty liver disease (NAFLD) activity score (NAS):>5].The levels of low-and high-density lipoprotein (LDL and HDL) cholesterol,as well as the levels of ALT and AST,were increased from the end of week 4 to the end of week 8 for the HFHFr and HF groups.At the end of week 16,the two groups differed in the extent of increase in total cholesterol and LDL and HDL cholesterol,with only the HFHFr group showing statistically significant changes.Specifically,at the end of week 16,the HFHFr group showed ALT levels of 108.5 ± 93.34 U/L (F=5.099,P =0.005 vs.HF group:44.30 ± 35.71 U/L,HFr group:46.70 ± 17.95 U/L,SC group:24.70 ± 6.57 U/L),AST levels of 316.30 ± 208.98 U/L (F=6.654,P=0.001 vs.HF:132.12 ± 75.43 U/L,HFr:143.30 ± 38.53 U/L,SC:122.60 ± 12.76 U/L),total cholesterol levels of 5.18 ± 0.58 mmol/L (F=72:470,P =0.000 vs.HF:3.94 ± 0.75 mmol/L,HFr:2.30 ± 0.50 mmol/L,SC:2.02 ± 0.24 mmol/L),HDL cholesterol levels of 3.05 ± 0.49 mmol/L (F =25.413,P =0.000 vs.HF:2.65 ± 0.54 mmol/L HFr:1.77 ± 0.47 mmol/L,SC:1.58 ± 0.16 mmol/L),LDL cholesterol levels of 1.11 ± 0.23 mmol/L (F =83.297,P =0.000 vs.HF:0.72 ± 0.17 mmol/L,HFr:0.27 ± 0.04 mmol/L,SC:0.20 ± 0.05 mmol/ L).Conelusion The present study suggests that a mouse model of NASH can be successfully induced by a 16-week modified HFHFr diet.